GenSight Biologics S.A.
GSGTF
$0.19
-$0.05-20.79%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.40% | 37.74% | 46.58% | 36.99% | 27.68% |
| Total Depreciation and Amortization | -68.48% | -60.05% | -51.41% | -5.36% | 83.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.81% | 86.10% | 71.75% | 101.19% | 116.51% |
| Change in Net Operating Assets | 376.20% | 79.01% | -64.36% | -25.97% | 204.04% |
| Cash from Operations | 48.84% | 48.54% | 47.52% | 49.52% | 50.93% |
| Capital Expenditure | 100.00% | 95.58% | 90.74% | 88.97% | 88.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -161.52% | -109.58% | -91.76% | -82.22% | -75.57% |
| Cash from Investing | -171.47% | -110.64% | -91.85% | -80.61% | -70.02% |
| Total Debt Issued | -- | -- | -- | -81.26% | -67.12% |
| Total Debt Repaid | -307.16% | -123.14% | -54.56% | 61.97% | 90.79% |
| Issuance of Common Stock | -72.99% | -3.10% | 253.73% | 576.74% | 5,492.69% |
| Repurchase of Common Stock | 95.87% | 85.45% | 72.73% | -49.49% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -62.07% | 125.98% | 900.97% | 304.69% | 197.85% |
| Cash from Financing | -92.02% | -59.53% | -14.65% | 37.71% | 126.03% |
| Foreign Exchange rate Adjustments | -537.62% | -414.26% | -346.46% | -187.89% | -54.17% |
| Miscellaneous Cash Flow Adjustments | -10.00% | 0.00% | -- | -200.00% | -200.00% |
| Net Change in Cash | -213.23% | -143.02% | 103.80% | 119.99% | 126.56% |